Related Experiment Video

Updated: Jul 15, 2026

Real-time Digital Imaging of Leukocyte-endothelial Interaction in Ischemia-reperfusion Injury (IRI) of the Rat Cremaster Muscle
15:07

Real-time Digital Imaging of Leukocyte-endothelial Interaction in Ischemia-reperfusion Injury (IRI) of the Rat Cremaster Muscle

Published on: August 5, 2012

[C-reactive protein: cardiovascular issues of an acute-phase protein]

Luis M Amezcua-Guerra1, Rashidi Springall del Villar, Rafael Bojalil Parra

  • 1Departamento de Inmunología, INCICH, Tlalpan, DF México.

Archivos De Cardiologia De Mexico
|May 16, 2007
PubMed

Insights

C-reactive protein (CRP) is an inflammatory marker and potential cardiovascular disease predictor. Recent studies indicate its association with cardiac events is weaker than previously thought, but statin therapy may reduce risks by lowering CRP levels.

Area of Science:

  • Biochemistry and Immunology
  • Cardiovascular Medicine

Background:

  • C-reactive protein (CRP) is a well-established inflammatory marker.
  • Emerging evidence suggests CRP's role in cardiovascular disease (CVD) prediction.
  • CRP functions include binding damaged lipoproteins and activating complement.

Purpose of the Study:

  • To evaluate the association between C-reactive protein levels and cardiovascular events.
  • To assess the impact of statin therapy on CRP levels and adverse cardiovascular outcomes.

Main Methods:

  • Analysis of large meta-analyses and prospective studies on CRP and cardiac events.
  • Investigation of statin therapy effects in coronary artery disease patients.

Main Results:

  • The independent association of CRP levels with cardiac events appears weaker than previously reported.
  • Statin therapy in coronary artery disease patients is linked to reduced adverse outcomes.
  • Statin-induced CRP reduction is independent of their lipid-lowering effects.

Conclusions:

  • While CRP is an inflammatory marker, its predictive power for cardiovascular events may be overestimated.
  • Statin therapy offers cardiovascular benefits potentially mediated by CRP reduction.
  • Further research is needed to fully elucidate CRP's role in cardiovascular pathophysiology and treatment.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...